As we reported earlier this week, the U.K. became the first nation to issue emergency authorization for the Pfizer experimental mRNA COVID vaccine, with jabs expected to start with the public any day now.

The UK Department of Health and Social Care and the Medicines & Healthcare products Regulatory Agency has just published guidelines for the roll out of Pfizer vaccine.

There is a 10-page document for UK Healthcare Professionals, and a shorter 5-page document for recipients. This is public information (for now), and Health Impact News has secured copies of each.

*** JdN My downloads of and from this document for health care personnel

UK-Info-healthcare-professionals-covid-vaccine-pfizer

Manufacturer
BioNTech Manufacturing GmbH
Kupferbergterrasse 17-19
55116 Mainz, Germany

https://www.biontech-imfs.de/about-us/team/

In the leaflet for recipients, it gives strict warnings to women who are pregnant and breast-feeding.

Pregnancy and breast-feeding
There is currently limited data available on the use of this vaccine in pregnant women. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before you receive this vaccine. As a precaution, you should avoid becoming pregnant until at least 2 months after the vaccine.

However, in the longer document issued to “Healthcare Professionals,” it gives an additional warning (see red highlight):

4.6 Fertility, pregnancy and lactation

Pregnancy
There are no or limited amount of data from the use of COVID-19 mRNA Vaccine BNT162b2. Animal reproductive toxicity studies have not been completed. COVID-19 mRNA Vaccine BNT162b2 is not recommended during pregnancy. For women of childbearing age, pregnancy should be excluded before vaccination. In addition, women of childbearing age should be advised to avoid pregnancy for at least 2 months after their second dose.

Breast-feeding
It is unknown whether COVID-19 mRNA Vaccine BNT162b2 is excreted in human milk. A risk to the newborns/infants cannot be excluded. COVID-19 mRNA Vaccine BNT162b2 should not be used during breast-feeding.

Fertility
It is unknown whether COVID-19 mRNA Vaccine BNT162b2 has an impact on fertility.

Why was this warning not included in the leaflet to be distributed to the recipients of the vaccine? The leaflet to the recipients starts out with this text:

Read all of this leaflet carefully before you receive this vaccine because it contains important information for you.

* Keep this leaflet. You may need to read it again.
* If you have any further questions, ask your doctor, pharmacist or nurse.
* If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. See section 4.

So after someone reads the shorter leaflet prior to deciding whether or not to get the vaccine, the only way a young woman would know about the warning about potential infertility issues, would be if they asked their doctor or other healthcare provider a specific question about fertility.

And even then, it is dependent upon that doctor having completely read the longer document, and answering the young woman’s question on fertility issues accurately.

If you live in the UK, please print out the longer document published for the doctors, and make sure everyone you know who is considering getting this vaccine reads it, and not just the shorter document published for “recipients.”

As we have previously reported, Dr. Michael Yeadon, the former head of Pfizer research,

filed a STAY OF ACTION with the European Medicines Agency, together with Dr. Wolfgang Wodarg, and he warned them about the potential effects of this vaccine on fertility, as he wrote that the experimental Pfizer COVID vaccine is:

expected to induce the formation of humoral antibodies against spike proteins of SARS-CoV-2. Syncytin-1 (see Gallaher, B., “Response to nCoV2019 Against Backdrop of Endogenous Retroviruses” – http://virological.org/t/response-to-ncov2019-against-backdrop-of-endogenous-retroviruses/396), which is derived from human endogenous retroviruses (HERV) and is responsible for the development of a placenta in mammals and humans and is therefore an essential prerequisite for a successful pregnancy, is also found in homologous form in the spike proteins of SARS viruses.

There is no indication whether antibodies against spike proteins of SARS viruses would also act like anti-Syncytin-1 antibodies. However, if this were to be the case, this would then also prevent the formation of a placenta which would result in vaccinated women essentially becoming infertile.

To my knowledge, Pfizer/BioNTech has yet to release any samples of written materials provided to patients, so it is unclear what, if any, information regarding (potential) fertility-specific risks caused by antibodies is included.

According to section 10.4.2 of the Pfizer/BioNTech trial protocol, a woman of childbearing potential (WOCBP) is eligible to participate if she is not pregnant or breastfeeding, and is using an acceptable contraceptive method as described in the trial protocol during the intervention period (for a minimum of 28 days after the last dose of study intervention).

This means that it could take a relatively long time before a noticeable number of cases of post-vaccination infertility could be observed. (Source.)

Why Only People Over the Age of 16?

The other issue brought out in these guidelines that raises serious questions, is why are they only recommending the vaccine for individuals over the age of 16? They state:

The safety and efficacy of COVID-19 mRNA Vaccine BNT162b2 in children under 16 years of age have not yet been established.

But one of the trial groups that tested the vaccine had children between the age of 12 and 15. From the longer document for doctors:

Study BNT162-01 (Study 1) enrolled 60 participants, 18 through 55 years of age. Study C4591001 (Study 2) enrolled approximately 44,000 participants, 12 years of age or older.

In Study 2, a total of 21,720 participants 16 years of age or older received at least one dose of COVID-19 mRNA Vaccine BNT162b and 21,728 participants 16 years of age or older received placebo.

Unless I am missing something here, or my math is off, if there were 44,000 participants in Study 2 that were 12 years of age and older, and “21,720 participants 16 years of age or older received at least one dose of COVID-19 mRNA Vaccine BNT162b and 21,728 participants 16 years of age or older received placebo,” then that means 552 participants were children between the age of 12 and 15.

That is more than the total of Study 1, which included only 60 participants between the age of 18 and 55.

So what happened to these children between the ages of 12 and 15? They were obviously included in the study for a reason. Did parents actually give their consent to include these children? Or were they wards of the Government having been medically kidnapped from their parents, so that consent was not necessary?

Also, what is the percentage of participants above the age of 55, the group most at risk?They were not even included in Study 1, for some reason.

Other Warnings

From the longer document issued to doctors:

4.4 Special warnings and precautions for use

Traceability

In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.

General recommendations

As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.

The administration of COVID-19 mRNA Vaccine BNT162b2 should be postponed in individuals suffering from acute severe febrile illness.

Individuals receiving anticoagulant therapy or those with a bleeding disorder that would contraindicate intramuscular injection, should not be given the vaccine unless the potential benefit clearly outweighs the risk of administration.

Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the vaccine. No data are available about concomitant use of immunosuppressants.

As with any vaccine, vaccination with COVID-19 mRNA Vaccine BNT162b2 may not protect all vaccine recipients.

No data are available on the use of COVID-19 mRNA Vaccine BNT162b2 in persons that have previously received a full or partial vaccine series with another COVID-19 vaccine.

Excipient information

This vaccine contains potassium, less than 1 mmol (39 mg) per dose, i.e. essentially ‘potassium-free’. This vaccine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium‑free’.

4.5 Interaction with other medicinal products and other forms of interaction

No interaction studies have been performed.

Concomitant administration of COVID-19 mRNA Vaccine BNT162b2 with other vaccines has not been studied (see section 5.1).

Do not mix COVID-19 mRNA Vaccine BNT162b2 with other vaccines/products in the same syringe.

4.8 Undesirable effects

Adverse reactions reported in clinical studies are listed in this section per MedDRA system organ class, in decreasing order of frequency and seriousness. The frequency is defined as follows: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from available data).

Blood and lymphatic system disorders

Uncommon: Lymphadenopathy

Nervous system disorders

Very common: Headache

Musculoskeletal and connective tissue disorders

Very common: Arthralgia; myalgia

General disorders and administration site conditions

Very common: Injection-site pain; fatigue; chills; pyrexia

Common: Redness at injection site; injection site swelling

Uncommon: Malaise

Gastrointestinal disorders

Common Nausea

Massive Amounts of Casualties Expected?

The Independent announced this week that the UK government has granted Pfizer legal indemnity protecting it from being suedfor any injuries or deaths due to the experimental COVID vaccine.

The UK government has granted pharmaceutical giant Pfizer a legal indemnity protecting it from being sued, enabling its coronavirus vaccine to be rolled out across the country as early as next week.

The Department of Health and Social Care has confirmed the company has been given an indemnity protecting it from legal action as a result of any problems with the vaccine.

Ministers have also changed the law in recent weeks to give new protections to companies such as Pfizer, giving them immunity from being sued by patients in the event of any complications.

NHS staff providing the vaccine, as well as manufacturers of the drug, are also protected.

In a press conference with journalists on Wednesday, Ben Osborn, Pfizer’s UK managing director, refused to explain why the company needed an indemnity.

He said: “We’re not actually disclosing any of the details around any of the aspects of that agreement and specifically around the liability clauses.” (Source.)

In October, the UK government’s Medicines & Healthcare products Regulatory Agency (MHRA), posted a bid request stating that “For reasons of extreme urgency,” they seek “an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs).”

The request goes on to explain that:

“it is not possible to retrofit the MHRA’s legacy systems to handle the volume of ADRs that will be generated by a Covid-19 vaccine,” and that this “represents a direct threat to patient life and public health.”

Time is Short for the U.K.!

The only thing that can now stop the possible genocide of a majority of the public in areas where this experimental vaccine is rolled out is massive public resistance.

The authorities in the U.K. are probably expecting this, especially given the recent protests against the lockdowns, so they are ready to deploy the military, just as President Trump is also doing in the U.S.

The British Army’s Information Warfare Unit is being deployed to deal with “anti-vaccine propaganda” heading into the rollout of the vaccine, The Daily Mail reports. The unit was launched in 2010 and is part of the Army’s 77th Brigade, which “often works with psychological operations”.

In fact, “soldiers are already monitoring cyberspace for Covid-19 content”, the report reveals. The move comes as a response to a growing number of both anti-lockdown and anti-vaccine protests. Late last week, for example, more than 155 anti-lockdown protesters organized in Central London, marching through Westminster and chanting “shame on you” and “freedom”.

Others waved signs reading “All I want for Christmas is my freedom back”, “Ditch the face masks” and “Stop controlling us”.

The country is implementing similar fines and restrictions for businesses as the U.S. government. And, similarly, businesses are starting to take matters into their own hands and defy lockdown orders. (Source.)

Spread this information far and wide while you still can. Print out and copy the videos from these articles as well, because an Internet blackout was part of the Event 201 Plandemic simulation, so we should expect that to happen at some point.